The Heart Institute of Japan Candesartan Randomized trial for Evaluation in Coronary Artery Disease
Not Applicable
- Conditions
- Coronary artery disease
- Registration Number
- JPRN-UMIN000000790
- Lead Sponsor
- HIJC Study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2030
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with socondary hypertension hypertrophic obstructive cardiomyopathy Acute myocardial infarction (withih 7 days) cerebrovascular disease within 3 months serum Creatinine >=2.0mg/dl hyperkalemia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint of the present study was the time to the first major adverse cardiovascular events.
- Secondary Outcome Measures
Name Time Method The major secondary endpoints included the incidence of coronary revascularization and new-onset diabetes.